Parexel Names Boris Braylyan Chief Data & Digital Officer

What happened

Parexel, the global clinical research organisation, has promoted Boris Braylyan to the role of Chief Data and Digital Officer (CDDO), elevating a senior internal leader to oversee the company's data strategy and digital transformation agenda. The appointment signals a deliberate move by Parexel to consolidate its data and digital functions under unified executive leadership.

Braylyan steps into the CDDO position having previously held a senior data and technology role within the organisation, reflecting a pattern of promoting from within to maintain strategic continuity. His remit will span data governance, digital innovation and the application of advanced analytics across Parexel's clinical trial operations.

Why it matters

For organisations operating at the intersection of complex service delivery and high-stakes customer outcomes — as clinical research organisations do — the elevation of a Chief Data and Digital Officer is rarely just a structural reshuffle. It is a signal about where decision-making authority over the patient and sponsor experience will sit. When data and digital capabilities report to a single C-suite leader, the organisation gains the architecture to move from fragmented touchpoint improvements to genuinely joined-up service journeys.

From a service-design perspective, the CRO sector is under mounting pressure to reduce friction for both trial sponsors and patients — two very different customer segments with divergent needs. Placing data strategy at the executive table is a prerequisite for the kind of behavioural insight and real-time personalisation that modern trial participants and pharmaceutical clients increasingly expect.

The Renascence take

Executive appointments in data and digital roles are routinely celebrated as transformation milestones, yet the harder question — whether the organisation's operating model will actually change around the new title — rarely gets asked loudly enough.

The risk with CDDO appointments is that they become permission structures rather than change engines. Parexel's move is meaningful only if Braylyan's mandate includes genuine authority over how data shapes the sponsor and patient experience end-to-end, not merely oversight of infrastructure. The behavioral economics principle at play here is accountability architecture: people change their decisions when they own outcomes, not just systems. A customer-obsessed operator should immediately ask: does this leader have a CX outcome metric attached to their role, or only a technology delivery one? That single distinction separates a digital transformation from a digital reorganisation.